The Bruckner Group, Inc. Release: Large-Scale Nationwide Study Of Hepatitis C Treatment Patterns Finds Nearly 30% Of Treatment Candidates Not Receiving Therapy
10/19/2005 5:11:24 PM
The Bruckner Group (BGI), a strategy and research firm for the pharmaceutical and biotechnology industries, today announced the results of a large-scale nationwide study on hepatitis C treatment patterns conducted with Brooke Army Medical Center. Select findings are being presented today at the Digestive Disease Week conference in New Orleans.
comments powered by